Brief: Crinetics Pharmaceuticals Q3 Net Income USD -76.828 Million
12/11/2024 21:05
Nov 12 (Reuters) - Crinetics Pharmaceuticals Q3 operating expenses USD 87.797 million. * Q3 basic EPS USD -0.96 * Q3 operating income USD -87.797 million
Recent news on Crinetics Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Crinetics Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Crinetics Q2 revenue jumps on PALSONIFY launch, withdraws guidance
Brief: Crinetics Pharmaceuticals Q2 Net Income USD -120.855 Million